down arrow

PainReform Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IL0011651580
USD
1.02
0.06 (6.26%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

0.961.07

52 Week

0.8016.63
Valuation
Technical
Day's Volume

CASH

84.97 k

Shareholding (Dec 2024)

FII

0.59%

Held by 4 FIIs

DII

99.13%

Held by 0 DIIs

Promoter

0.27%

How big is PainReform Ltd.?

22-Jun-2025

As of Jun 18, PainReform Ltd. has a market capitalization of 3.46 million, categorizing it as a Micro Cap company, with net sales of 0.00 million and a consolidated net profit of -17.67 million over the latest four quarters.

Market Cap: As of Jun 18, PainReform Ltd. has a market capitalization of 3.46 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, PainReform Ltd. reported net sales of 0.00 million and a consolidated net profit of -17.67 million.<BR><BR>Balance Sheet Snapshot: As of Dec'24, the company's shareholder's funds stand at 1.82 million, while total assets are reported at 4.53 million.

Read More

What does PainReform Ltd. do?

22-Jun-2025

PainReform Ltd. is an Israeli pharmaceutical company specializing in the reformulation of existing pain medications, classified as a micro-cap with a market cap of USD 3.46 million and a recent net profit of -7 million.

Overview:<BR>PainReform Ltd. is an Israel-based pharmaceutical company focused on the reformulation of established pain therapeutics, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>- Most recent Net Profit: -7 Million (Quarterly Results - Jun 2024)<BR>- Market-cap: USD 3.46 Million (Micro Cap)<BR><BR>Key Metrics:<BR>- Debt Equity: 1.34<BR>- Return on Equity: -961.02%<BR>- Price to Book: 1.90<BR><BR>Contact Details:<BR>- Address: 4 Bruria St., TEL AVIV-YAFO None: 6745442<BR>- Tel: 972 9 9601901<BR>- Fax: 972 9 9542266<BR>- Website: http://www.painreform.com

Read More

Is PainReform Ltd. technically bullish or bearish?

20-Sep-2025

As of September 5, 2025, PainReform Ltd. is in a mildly bearish trend, with significant underperformance at -57.68% year-to-date compared to the S&P 500's 12.22%, driven by bearish signals from moving averages and Bollinger Bands despite some mildly bullish indicators.

As of 5 September 2025, the technical trend for PainReform Ltd. has changed from sideways to mildly bearish. The current stance is bearish, primarily driven by the daily moving averages indicating a bearish trend, while the Bollinger Bands show a mildly bearish to bearish outlook on the weekly and monthly time frames. Although the MACD and KST are mildly bullish on the weekly and monthly charts, they are overshadowed by the bearish signals from the moving averages and Bollinger Bands. <BR><BR>In terms of performance, PainReform has significantly underperformed compared to the S&P 500, with a year-to-date return of -57.68% versus the S&P 500's 12.22%, and a one-year return of -57.23% compared to the S&P 500's 17.14%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 3 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.34

stock-summary
Return on Equity

-961.02%

stock-summary
Price to Book

1.53

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2024)
Net Profit:
-7 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-27.66%
0%
-27.66%
6 Months
-49.5%
0%
-49.5%
1 Year
-64.21%
0%
-64.21%
2 Years
-98.32%
0%
-98.32%
3 Years
131.82%
0%
131.82%
4 Years
-99.74%
0%
-99.74%
5 Years
-99.9%
0%
-99.9%

PainReform Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is PainReform Ltd. technically bullish or bearish?

As of 5 September 2025, the technical trend for PainReform Ltd. has changed from sideways to mildly bearish. The current stance is bearish, primarily driven by the daily moving averages indicating a bearish trend, while the Bollinger Bands show a mildly bearish to bearish outlook on the weekly and monthly time frames. Although the MACD and KST are mildly bullish on the weekly and monthly charts, they are overshadowed by the bearish signals from the moving averages and Bollinger Bands. In terms of performance, PainReform has significantly underperformed compared to the S&P 500, with a year-to-date return of -57.68% versus the S&P 500's 12.22%, and a one-year return of -57.23% compared to the S&P 500's 17.14%....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-266.98%
EBIT to Interest (avg)
-13.80
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-2.32
Sales to Capital Employed (avg)
0
Tax Ratio
0.05%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
8.01%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.27
EV to EBIT
0.00
EV to EBITDA
EV to Capital Employed
0.03
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
742.13%
ROE (Latest)
-961.02%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 1 Schemes (0.01%)

Foreign Institutions

Held by 4 Foreign Institutions (0.59%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2024 is 0.00% vs 0.00% in Jun 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2024 is -231.82% vs -22.22% in Jun 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'24",
        "Jun'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-7.30",
          "val2": "-2.20",
          "chgp": "-231.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-7.30",
          "val2": "-2.20",
          "chgp": "-231.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -56.99% vs -5.68% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-14.70",
          "val2": "-9.60",
          "chgp": "-53.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.40",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.20",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-14.60",
          "val2": "-9.30",
          "chgp": "-56.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'24 - YoYstock-summary
Jun'24
Jun'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-7.30
-2.20
-231.82%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-7.30
-2.20
-231.82%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in quarter ended Jun 2024 is 0.00% vs 0.00% in Jun 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2024 is -231.82% vs -22.22% in Jun 2023

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-14.70
-9.60
-53.12%
Interest
0.00
0.40
-100.00%
Exceptional Items
0.00
0.20
-100.00%
Consolidate Net Profit
-14.60
-9.30
-56.99%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -56.99% vs -5.68% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About PainReform Ltd. stock-summary
stock-summary
PainReform Ltd.
Pharmaceuticals & Biotechnology
PAINREFORM LTD is a Israel-based pharmaceutical Company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.
Company Coordinates stock-summary
Company Details
4 Bruria St. , TEL AVIV-YAFO None : 6745442
stock-summary
Tel: 972 9 9601901
stock-summary
http://www.painreform.com
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."